MedPath

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Phase 3
Completed
Conditions
Coagulopathy
Severe Sepsis
Interventions
Drug: Placebo
Registration Number
NCT01598831
Lead Sponsor
Asahi Kasei Pharma America Corporation
Brief Summary

The purpose of the study is to evaluate if ART-123 given to patients who have severe sepsis can decrease mortality.

Detailed Description

Study is to evaluate if ART-123 given to patients who have severe sepsis complicated by at least one organ dysfunction and coagulopathy can decrease mortality.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
816
Inclusion Criteria
  • Subject must be receiving treatment in an ICU, or in an acute care setting (e.g., ER, RR)
  • Clinical objective evidence of bacterial infection and a known site of infection.
  • Cardiovascular dysfunction or Respiratory Failure due to sepsis.
  • Coagulopathy characterized by an INR >1.40 without other known causes.
Exclusion Criteria
  • Subject or Authorized Representative is unable to provide informed consent.
  • Subject is pregnant or breastfeeding or intends to get pregnant within 28 days of enrolling into the study.
  • Subject is of childbearing potential and does not have a negative pregnancy test.
  • Subject is < 18 years of age.
  • Subject has a known allergy to ART-123 or any components of the drug product.
  • Subject is unwilling to allow transfusion of blood or blood products.
  • Subject has an advance directive to withhold life-sustaining treatment.
  • Subject has had previous treatment with ART-123.
  • Body weight ≥ 175 kg.
  • Platelets < 30,000/ mm3 for any reason, PT prolongation or thrombocytopenia that is not due to sepsis.
  • Any surgery that is potentially hemorrhagic (e.g. intra-thoracic, intra-abdominal or non-traumatic orthopedic surgery of the femur or pelvis) that is completed within 12 hours prior to first dose of study drug, or ongoing impairment of hemostasis as a result of one of these procedures
  • History of head trauma, spinal trauma, or other acute trauma with an increased risk of bleeding within 3 months prior to consent.
  • Cerebral Vascular Accident (CVA) within 3 months prior to consent.
  • Any history of intracerebral arteriovenous malformation (AVM), cerebral aneurysm, or mass lesions of the central nervous system.
  • History of congenital bleeding diathesesor anatomical anomaly that predisposes to hemorrhage (e.g. hemophilia, hereditary hemorrhagic telangiectasia).
  • Significant gastrointestinal bleeding within 6 weeks prior to consent.
  • Subject is diagnosed with a known medical condition associated with a hypercoagulable state.
  • Child-Pugh score of 10-15 (Class C)
  • Portosystemic hypertension or known history of bleeding esophageal varices.
  • History of solid organ, allogeneic bone marrow, or stem cell transplantation within the 6 months prior to consent.
  • Acute pancreatitis where infection has not been documented by a positive blood or abdominal fluid culture or gram stain consistent with bacterial infection.
  • Subjects with renal dysfunction defined as (a) Chronic renal failure requiring renal replacement therapy (RRT), or (b) Acute renal failure with onset of oliguria (urine output < 0.3 ml/kg/hr) > 48 hours prior to first dose of study drug whether receiving RRT or not
  • Use of anticoagulants, antiplatelet agents, antithrombotics and thrombolytics within the 72 hours prior to first does of study drug.
  • Life expectancy < 90 days.
  • Current use of any chemotherapy agent likely to cause myeloablation (severe or complete depletion of bone marrow).
  • Participation in another research study involving an investigational agent within 30 days prior to consent or projected study participation during the 28 days post study randomization.
  • Confirmed or suspected endocarditis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
ART-123ART-123-
Primary Outcome Measures
NameTimeMethod
Number of Participants With 28-Day All-cause Mortality28 days

28-Day All-cause Mortality

Number of Participants With On-Treatment Serious Major Bleeding EventsThrough Study Day 28

On-treatment Serious Major Bleeding Events collected as Serious Adverse Events and defined as: any intracranial hemorrhage, any life-threatening bleeding, any bleeding event classified as serious by the Investigator (e.g., resulting in permanent morbidity), or any bleeding that required the administration of 1440 ml (typically 6 units) of packed red cells over two consecutive days. (Investigator assessment for seriousness criteria.)

Secondary Outcome Measures
NameTimeMethod
Follow up All-cause Mortality at 3 Months3 months

Follow up all-cause mortality at 3 months

Number of Event Free and Alive Days to Measure Resolution of Organ Dysfunction28 days

Resolution of organ dysfunction as measured through day 28 by shock free, ventilator free, dialysis free plus alive days.

Number of Participants With Anti-drug Antibodies18 months

Presence of Anti-drug antibodies up to 18 months

Trial Locations

Locations (131)

Washington University in St. Louis

🇺🇸

Saint Louis, Missouri, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

2 of 2

🇨🇦

Ottawa, Ontario, Canada

Prince of Wales Hospital

🇦🇺

Randwick, New South Wales, Australia

Princess Alexandra Hospital

🇦🇺

Woolloongabba, Queensland, Australia

Bendigo Hospital

🇦🇺

Bendigo, Victoria, Australia

UZ Antwerpen

🇧🇪

Antwerpen, Belgium

UCL St. Luc

🇧🇪

Brussels, Belgium

Hopitaux Iris Sud

🇧🇪

Brussels, Belgium

UZ Brussel

🇧🇪

Brussels, Belgium

Centre Hospitalier de Dinant

🇧🇪

Dinant, Belgium

Clinique Saint-Pierre

🇧🇪

Ottignies, Belgium

UZ Gent

🇧🇪

Gent, Belgium

UCL Mont-Godinne

🇧🇪

Yvoir, Belgium

Santa Casa de Misericordia de Belo Horizonte

🇧🇷

Belo Horizonte, MG, Brazil

Hospital Pompéia

🇧🇷

Brasil, Brazil

Department of Anesthesiology and Intensive Care Multiprofile Hospital For Active Treatment "Tokuda Hospital Sofia", Sofia

🇧🇬

Sofia, Bulgaria

Anesthesiology and Intensive Care Clinic, University Multiprofile Hospital For Active Treatment "Sveti Georgi", Plovdiv

🇧🇬

Plovdiv, Bulgaria

Clinical Hospital Dubrava, Department of Anesthesiology and resuscitation

🇭🇷

Zagreb, Croatia

University Hospital Center Zagreb, Department of Anesthesiology, Reanimatology and Intensive Care Medicine

🇭🇷

Zagreb, Croatia

1 of 2

🇨🇦

Ottawa, Ontario, Canada

Clinical Hospital Center Zagreb, Medical ICU

🇭🇷

Zagreb, Croatia

University Hospital Brno, Department of Infectious Diseases

🇨🇿

Brno, Czechia

University Hospital Hradec Kralove, Department of Anaesthesiology, Resuscitation and Intensive Care

🇨🇿

Hradec Kralove, Czechia

University Hospital Kralovske Vinohrady, Department of Anesthesiology and Resuscitation

🇨🇿

Prague 10, Czechia

General University Hospital in Prague, Department of Anaesthesiology, Resuscitation and Intensive Medicine

🇨🇿

Prague 2, Czechia

Masaryk´s Hospital Ustni nad Labem, o.z., Department of Infectious Diseases

🇨🇿

Usti nad Labem, Czechia

Keski-Suomen Keskussairaala (Central Finland Central Hospital)

🇫🇮

Jyväskylä, Finland

Tampereen Yliopistollinen Sairaala (Tampere University Hospital) (TAYS) - Keskussairaala (Central Hospital)

🇫🇮

Tampere, Finland

Kuopion Yliopistollinen Sairaala (KYS) (Kuopio University Hospital)

🇫🇮

Kuopio, Finland

CHU D'Anger

🇫🇷

Angers Cedex 9, France

Archet 1 University Hospital of Nice

🇫🇷

Nice, Cedex 3, France

CHU de Dijon, Hopital Bocage Central

🇫🇷

Dijon, France

Service de reanimation médicale. CHU Hotel Dieu

🇫🇷

Nantes, Nantes Cedex 01, France

CHU Limoges

🇫🇷

Limoges cedex, France

CHRU Lille-Pole Reanimation

🇫🇷

Lille, France

Hôpital COCHIN

🇫🇷

Paris, France

University Hospital of Bordeaux

🇫🇷

Pessac, France

Centre Hospitalier Universitaire Nîmes

🇫🇷

Nîmes Cedex 9, France

La Pitié Salpétrière, Paris

🇫🇷

Paris, France

CH Lyon Sud

🇫🇷

Pierre-Bénite cedex, France

CHU Tours, Hopital Bretonneau

🇫🇷

Tours, France

Universitätsklinikum der RWTH Aachen

🇩🇪

Aachen, Germany

Szent Imre Hospital, Anesthesiology and Intensive Care Unit

🇭🇺

Budapest, Hungary

Helios Klinikum Erfurt

🇩🇪

Erfurt, Germany

Klinikum der Johann-Wolfgang Goethe-Universität

🇩🇪

Frankfurt am Main, Germany

Shalby

🇮🇳

Ahmedabad, Gujarat, India

Shalby Hospital

🇮🇳

Ahmedabad,, Gujarat, India

Noble Hospital

🇮🇳

Pune, India

Artemis Hospital

🇮🇳

Gurgaon, Haryana, India

Hi-tech Medical College & Hospital

🇮🇳

Bhubaneswar, Odisha, India

Bharati Vidyapeeth Deemed University Medical College Bharti Hospital and Research Centre

🇮🇳

Pune, Pune, Maharashtra, India

St. Theresa Hospital

🇮🇳

Hyderabad, Telangana State, India

JSS Hospital

🇮🇳

Mysore, India

Kaplan Medical Center

🇮🇱

Rehovot, Israel

Care Hospital

🇮🇳

Nagpur, India

The Lady Davis Carmel Medical Center

🇮🇱

Haifa, Israel

Barzilai Medical Center

🇮🇱

Ashkelon, Israel

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center [Pulmonology]

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seongdu, Korea, Republic of

Jeroen Bosch Ziekenhuis

🇳🇱

's-Hertogenbosch, Netherlands

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Medisch Spectrum Twente

🇳🇱

Enschede, Netherlands

Ziekenhuis Gelderse Vallei

🇳🇱

Ede, Netherlands

VUMC

🇳🇱

Amsterdam, Netherlands

Medisch Centrum Leeuwarden

🇳🇱

Leeuwarden, Netherlands

UMC St. Radboud

🇳🇱

Nijmegen, Netherlands

Ikazia Ziekenhuis

🇳🇱

Rotterdam, Netherlands

Auckland District Health Board

🇳🇿

Auckland, New Zealand

Christchurch Hospital

🇳🇿

Christchurch, New Zealand

Arkhangelsk Regional Clinical Hospital

🇷🇺

Arkhangelsk, Russian Federation

Wellington District Health Board

🇳🇿

Newtown, New Zealand

Hawkes Bay Regional Hospital Intensive Care Unit Omahu Road

🇳🇿

Hastings, New Zealand

Hospital Nacional Almenara Yrigoyen - EsSALUD

🇵🇪

Lima, Lima Province, Peru

Hospital Nacional FAP

🇵🇪

Lima, Lima Province, Peru

Volosevich City Clinical Hospital #1

🇷🇺

Arkhangelsk, Russian Federation

City Clinical Hospital #3 n.a. M.A. Pogorbunskiy

🇷🇺

Kemerovo, Russian Federation

St George City Hospital

🇷🇺

Saint Petersburg, Russian Federation

Vishnevsky Institute of Surgery

🇷🇺

Moscow, Russian Federation

City Hospital #40

🇷🇺

Saint Petersburg, Russian Federation

City Hospital #4

🇷🇺

Sochi, Russian Federation

Aleksandrovskaya City Hospital

🇷🇺

St. Petersburg, Russian Federation

Mariinskaya City Hospital

🇷🇺

St. Petersburg, Russian Federation

Mechnikov North-Western State Medical University n.a. I.I. Mechnikov

🇷🇺

St. Petersburg, Russian Federation

Complexo Hospitalario Universitario A Coruña

🇪🇸

A Coruña, Spain

Hospital Universitario Mutua Terrassa Intensive Care

🇪🇸

Barcelona, Spain

Servicio de Medicina Intensiva Hospital Universitario Valle de Hebron

🇪🇸

Barcelona, Spain

Hospital de Sabadell

🇪🇸

Sabadell, Spain

Hospital Clínico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitari de Tarragona Joan XXIII

🇪🇸

Tarragona, Spain

Taichung Veterans General Hospital [Pulmonology]

🇨🇳

Taichung, Taiwan

Birmingham Heartlands Hospital

🇬🇧

Birmingham, United Kingdom

Hull Royal Infirmary

🇬🇧

Hull, United Kingdom

Manchester Royal Infirmary

🇬🇧

Manchester, United Kingdom

Derriford Hospital

🇬🇧

Plymouth, United Kingdom

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

Maulana Azad Medical College and Associated L N Hospital

🇮🇳

New Delhi, Delhi, India

Rambam Medical Center

🇮🇱

Haifa, Israel

Cliniques Du Sud-Luxerbourg (CSL), Hospital Saint Joseph

🇧🇪

Arlon, Belgium

Mazumdar Shaw Medical Centre (Unit of Narayana Health)

🇮🇳

Bangalore, India

KLES Dr. Prabhakar Kore Hospital & Medical Research Centre

🇮🇳

Belgaum, India

Rabin Medical Center

🇮🇱

Petach Tikva, Israel

Kuban State Medical University (Site Facility: Krasnodar Regional Clinical Hospital #2)

🇷🇺

Krasnodar, Russian Federation

Krasnoyarsk Regional Clinocal Hospital

🇷🇺

Krasnoyarsk, Russian Federation

Clinic for Infectious Diseases, Clinical Center Nis

🇷🇸

Nis, Serbia

Chi Mei Medical Center Yong Kang

🇨🇳

Yongkang, Tainan, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Sinai-Grace Hospital

🇺🇸

Detroit, Michigan, United States

Royal Brisbane and Women's Hospital

🇦🇺

Herston, Queensland, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

King Edward Memorial Hospital & Research Centre

🇮🇳

Pune, Maharashtra, India

CH-Hôpital Albert Michallon

🇫🇷

Grenoble cedex 09, France

Centre Hospitalier Départemental de Vendée-Les Oudairies

🇫🇷

La Roche-Sur-Yon cedex 9, France

Nouvel hospital civil

🇫🇷

Strasbourg, France

Hôpital Sainte Musse

🇫🇷

Toulon, France

Fundaçao Faculdade Regional de Medicina Sao Jose do Rio Preto

🇧🇷

Sao Jose do Rio Preto, SP, Brazil

Detroit Receiving Hospital

🇺🇸

Detroit, Michigan, United States

CHU Brugmann

🇧🇪

Brussels, Belgium

Dandenong Hospital Monash Health

🇦🇺

Dandenong, Victoria, Australia

Western Hospital

🇦🇺

Footscray, Victoria, Australia

Austin Health

🇦🇺

Heidelberg, Victoria, Australia

Hospital Italiano de Cordoba

🇦🇷

Cordoba, Argentina

Helsingin Yliopistollinen Keskussairaala (HYKS) (Helsinki University Central Hospital (HUCH))

🇫🇮

Helsinki, Finland

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

Harper Hospital - Wayne State University School of Medicine

🇺🇸

Detroit, Michigan, United States

Sunshine Hospital

🇦🇺

Melbourne, Victoria, Australia

Hopital Erasme

🇧🇪

Brussels, Belgium

Monash Medical Centre

🇦🇺

Clayton, Victoria, Australia

Ruby Hall Clinic

🇮🇳

Pune, Maharashtra, India

Royal Liverpool University Hospital

🇬🇧

Liverpool, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath